Minimizing and Managing Toxicities From BTK Inhibitor Therapy: An Interactive Tool to Optimize the Therapeutic Benefit for Patients

Learn how the experts would manage toxicities associated with BTK inhibitor therapies with our newly updated Interactive Decision Support Tool. Then gain multidisciplinary insights into toxicity prevention and management with downloadable slides expert commentary and an informational resource aimed at patients and caregivers.

Share

Program Content

Activities

Managing AEs: BTK Inhibitors
An Interactive Tool for Managing BTK Inhibitor−Associated AEs in Hematologic Malignancies
Tool
Congratulations: You achieved a completion on 04/09/2022

Released: December 06, 2021

Expires: December 05, 2022

Activities

Counseling on BTKis
The Nurse’s Role in Counseling Patients Starting BTK Inhibitors
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 15, 2021

Expires: July 14, 2022

Activities

BTKi Patient Resource
BTK Inhibitor Therapy: A Guide for Patients and Their Caregivers on Avoiding and Managing Side Effects
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: August 25, 2021

Expires: August 24, 2022

Activities

Managing BTK Inhibitor Toxicities
Optimizing the Use of BTK Inhibitors in B-Cell Malignancies: Addressing BTK Inhibitor Toxicities
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: September 29, 2021

Expires: September 28, 2022

Addressing BTKi Toxicity
Addressing BTK Inhibitor Toxicities in B-Cell Malignancies
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: September 29, 2021

Expires: September 28, 2022

Faculty

cover img faculity

Farrukh Awan, MD, MS

Associate Professor of Internal Medicine
Division of Hematology
The Ohio State University Comprehensive Cancer Center
Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
Columbus, Ohio

cover img faculity

Beth Faiman, PhD, MSN, APRN-BC, AOCN, BMTCN, FAAN, FAPO

Cleveland Clinic Taussig Cancer Institute
Department of Hematology and Medical Oncology
Member, Population and Cancer Prevention Program
Case Comprehensive Cancer Center
Cleveland, Ohio

cover img faculity

Christopher R. Flowers, MD, MS

Department Chair
Department of Lymphoma/Myeloma, Division of Cancer Medicine
University of Texas MD Anderson Cancer Center
Houston, Texas

cover img faculity

Nicole Lamanna, MD

Associate Professor of Medicine
Director, CLL Program
Columbia University Medical Center
New York, New York

cover img faculity

John P. Leonard, MD

Senior Associate Dean for Innovation and initiatives
Chair (Interim), Weill Department of Medicine
Richard T. Silver Distinguished Professor of Hematology and Medical Oncology
Weill Cornell Medicine/NewYork-Presbyterian
New York, New York

cover img faculity

Anthony Perissinotti, PharmD, BCOP

Hematology Clinical Pharmacist Specialist
Clinical Team Leader
, Hematology/Oncology
Adjunct Clinical Assistant Professor
University of Michigan, Michigan Medicine
Roger Cancer Center
Ann Arbor, Michigan

cover img faculity

Julie M. Vose, MD

Neumann M. and Mildred E. Harris Professor
Chief
, Section of Hematology/Oncology
Professor of Medicine
University of Nebraska Medical Center
Omaha, Nebraska

Provided by

ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

BeiGene Ltd